| scholarly article | Q13442814 |
| P50 | author | Priscille Brodin | Q42158119 |
| José A Aínsa | Q55298982 | ||
| Liliana Rodrigues | Q55755990 | ||
| P2093 | author name string | Ok-Ryul Song | |
| Mercedes Maqueda | |||
| Nathalie Deboosère | |||
| Rubén Cebrián | |||
| Begoña Gracia | |||
| Asunción Vitoria | |||
| Clara Aguilar-Pérez | |||
| P2860 | cites work | Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin | Q24675831 |
| Structure of Bacteriocin AS-48: From Soluble State to Membrane Bound State | Q27642562 | ||
| Towards a new combination therapy for tuberculosis with next generation benzothiazinones | Q27681604 | ||
| Bacteriocins of lactic acid bacteria: extending the family | Q28074011 | ||
| High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors | Q28471626 | ||
| The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis | Q28486587 | ||
| Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis | Q29615255 | ||
| Neutral red uptake assay for the estimation of cell viability/cytotoxicity | Q30047632 | ||
| Analysis of the genome of Mycobacterium tuberculosis H37Rv | Q31913699 | ||
| Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain. | Q34134872 | ||
| AS-48 bacteriocin: close to perfection. | Q34185754 | ||
| Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains | Q34318969 | ||
| Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. | Q34616362 | ||
| Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis | Q36364079 | ||
| Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections | Q36393640 | ||
| A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra | Q36452856 | ||
| The membrane as a target for controlling hypervirulent Clostridium difficile infections | Q36963920 | ||
| Are bacteriocins underexploited? Novel applications for old antimicrobials | Q37862317 | ||
| Interaction between antimicrobial peptides and mycobacteria | Q38724994 | ||
| The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts. | Q39021587 | ||
| The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro. | Q39196411 | ||
| Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. | Q39335226 | ||
| Anti-mycobacterial peptides: made to order with delivery included | Q39713155 | ||
| Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy | Q40513871 | ||
| Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island | Q40680059 | ||
| In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis | Q41569899 | ||
| Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents | Q41695546 | ||
| Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs | Q42085729 | ||
| Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria | Q43024258 | ||
| Effect of combined physico-chemical preservatives on enterocin AS-48 activity against the enterotoxigenic Staphylococcus aureus CECT 976 strain. | Q47373378 | ||
| Inactivation of Clostridium difficile spore outgrowth by synergistic effects of nisin and lysozyme. | Q51083862 | ||
| Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain. | Q52919936 | ||
| EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. | Q54022193 | ||
| Potential Applications of the Cyclic Peptide Enterocin AS-48 in the Preservation of Vegetable Foods and Beverages | Q56831789 | ||
| Measuring Efflux and Permeability in Mycobacteria | Q57656378 | ||
| Action of lysozyme and nisin mixtures against lactic acid bacteria | Q73028474 | ||
| Synergy, antagonism, and what the chequerboard puts between them | Q73521098 | ||
| Antimycobacterial activity of bacteriocins and their complexes with liposomes | Q79906116 | ||
| Mechanisms of drug combinations: interaction and network perspectives | Q83265745 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| ethambutol | Q412318 | ||
| Bacteriocins | Q56831697 | ||
| P577 | publication date | 2018-09-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis | |
| P478 | volume | 62 |
| Q64249333 | Benefits and Inputs From Lactic Acid Bacteria and Their Bacteriocins as Alternatives to Antibiotic Growth Promoters During Food-Animal Production |
| Q92432079 | Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA |
| Q64103370 | Insights into Chagas treatment based on the potential of bacteriocin AS-48 |
| Q92279180 | Preclinical studies of toxicity and safety of the AS-48 bacteriocin |
Search more.